Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Autologous Alternative Vein Grafts for Infrainguinal Bypass in the Absence of Single-Segment Great Saphenous Vein: A Single-Center Study

E. Biroš, R. Staffa, M. Krejčí, T. Novotný, M. Skotáková, R. Bobák

. 2024 ; 103 (-) : 133-140. [pub] 20240228

Language English Country Netherlands

Document type Journal Article, Observational Study

BACKGROUND: Alternative autologous veins can be used as a conduit when adequate great saphenous vein is unavailable. We analyzed the results of our infrainguinal bypasses after adopting upper extremity veins in our practice. METHODS: This is a single-center observational study involving all patients whose infrainguinal bypass involved the use of upper extremity veins between April 2019, when we began using arm veins, and February 2023. RESULTS: During the study period, 49 bypasses were done in 48 patients; mean age 68.1 ± 9.8; men 32 (66.7%); body mass index 28.0 ± 4.8; indications for surgery: chronic limb threatening ischemia 41 (83.7%); acute limb ischemia 3 (6.1%); complications of previous prosthetic 3 (6.1%), or autologous 2 (4.1%) bypass grafts. Vein splicing was used in 43 (87.8%) bypasses with 3-segment grafts being the most common (26; 53.1%). There were 24 (49.0%) femorotibial, 11 (22.4%) femoropopliteal, 9 (18.4%) femoropedal, and 5 (10.2%) extension jump bypass procedures. Eighteen (36.7%) operations were redo surgeries. Twenty-one (42.9%) bypasses were formed using only arm veins. The median follow-up was 12.9 months (4.5-24.2). Two bypasses occluded during the first 30 postoperative days (2/49; 4.1%). Overall 30-day, 1-year, and 2-year primary patency rates were 93.7% ± 3.5%, 84.8% ± 5.9%, and 80.6% ± 6.9%, and secondary patency (SP) rates were 95.8% ± 2.9%, 89.2% ± 5.3%, and 89.2% ± 5.3%. One-segment grafts had better patencies than 2-, 3-, and 4-segment grafts (1-year SP 100% ± 0% vs 87.6% ± 6.0%). Two-year amputation-free survival was 86.8% ± 6.5%; 2-year overall survival was 88.2% ± 6.6%. CONCLUSIONS: Integration of arm vein grafts in infrainguinal bypass practice can be done safely with low incidences of perioperative graft failure. One-segment grafts had better patencies than spliced vein grafts. The achieved early patency and amputation-free survival rates strongly encourage their use. In the absence of a single-segment great saphenous vein, upper extremity vein grafts should be the preferred conduit choice.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013768
003      
CZ-PrNML
005      
20240905133819.0
007      
ta
008      
240725e20240228ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.avsg.2023.12.067 $2 doi
035    __
$a (PubMed)38428452
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Biroš, Ernest $u 2nd Department of Surgery, Centre for Vascular Disease, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic. Electronic address: ernest.biros@fnusa.cz
245    10
$a Autologous Alternative Vein Grafts for Infrainguinal Bypass in the Absence of Single-Segment Great Saphenous Vein: A Single-Center Study / $c E. Biroš, R. Staffa, M. Krejčí, T. Novotný, M. Skotáková, R. Bobák
520    9_
$a BACKGROUND: Alternative autologous veins can be used as a conduit when adequate great saphenous vein is unavailable. We analyzed the results of our infrainguinal bypasses after adopting upper extremity veins in our practice. METHODS: This is a single-center observational study involving all patients whose infrainguinal bypass involved the use of upper extremity veins between April 2019, when we began using arm veins, and February 2023. RESULTS: During the study period, 49 bypasses were done in 48 patients; mean age 68.1 ± 9.8; men 32 (66.7%); body mass index 28.0 ± 4.8; indications for surgery: chronic limb threatening ischemia 41 (83.7%); acute limb ischemia 3 (6.1%); complications of previous prosthetic 3 (6.1%), or autologous 2 (4.1%) bypass grafts. Vein splicing was used in 43 (87.8%) bypasses with 3-segment grafts being the most common (26; 53.1%). There were 24 (49.0%) femorotibial, 11 (22.4%) femoropopliteal, 9 (18.4%) femoropedal, and 5 (10.2%) extension jump bypass procedures. Eighteen (36.7%) operations were redo surgeries. Twenty-one (42.9%) bypasses were formed using only arm veins. The median follow-up was 12.9 months (4.5-24.2). Two bypasses occluded during the first 30 postoperative days (2/49; 4.1%). Overall 30-day, 1-year, and 2-year primary patency rates were 93.7% ± 3.5%, 84.8% ± 5.9%, and 80.6% ± 6.9%, and secondary patency (SP) rates were 95.8% ± 2.9%, 89.2% ± 5.3%, and 89.2% ± 5.3%. One-segment grafts had better patencies than 2-, 3-, and 4-segment grafts (1-year SP 100% ± 0% vs 87.6% ± 6.0%). Two-year amputation-free survival was 86.8% ± 6.5%; 2-year overall survival was 88.2% ± 6.6%. CONCLUSIONS: Integration of arm vein grafts in infrainguinal bypass practice can be done safely with low incidences of perioperative graft failure. One-segment grafts had better patencies than spliced vein grafts. The achieved early patency and amputation-free survival rates strongly encourage their use. In the absence of a single-segment great saphenous vein, upper extremity vein grafts should be the preferred conduit choice.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a senioři $7 D000368
650    12
$a průchodnost cév $7 D014654
650    _2
$a lidé středního věku $7 D008875
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    12
$a onemocnění periferních arterií $x chirurgie $x patofyziologie $x diagnostické zobrazování $7 D058729
650    _2
$a rizikové faktory $7 D012307
650    12
$a autologní transplantace $7 D014182
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a vény $x transplantace $x chirurgie $x patofyziologie $7 D014680
650    _2
$a vena saphena $x transplantace $7 D012501
650    _2
$a transplantace cév $x škodlivé účinky $x metody $7 D058017
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a záchrana končetiny $7 D023821
650    _2
$a okluze cévního štěpu $x etiologie $x patofyziologie $x chirurgie $7 D006083
650    _2
$a horní končetina $x krevní zásobení $7 D034941
650    _2
$a amputace $7 D000671
650    _2
$a reoperace $7 D012086
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Staffa, Robert $u 2nd Department of Surgery, Centre for Vascular Disease, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Krejčí, Miroslav $u 2nd Department of Surgery, Centre for Vascular Disease, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Novotný, Tomáš $u 2nd Department of Surgery, Centre for Vascular Disease, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Skotáková, Monika $u Biostatistics, International Clinical Research Centre of St. Anne's University Hospital, Brno, Czech Republic
700    1_
$a Bobák, Robert $u 2nd Department of Surgery, Centre for Vascular Disease, Faculty of Medicine, Masaryk University and St. Anne's University Hospital, Brno, Czech Republic
773    0_
$w MED00005646 $t Annals of vascular surgery $x 1615-5947 $g Roč. 103 (20240228), s. 133-140
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38428452 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905133813 $b ABA008
999    __
$a ok $b bmc $g 2143525 $s 1225634
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 103 $c - $d 133-140 $e 20240228 $i 1615-5947 $m Annals of vascular surgery $n Ann Vasc Surg $x MED00005646
LZP    __
$a Pubmed-20240725

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...